Skip to main content
Premium Trial:

Request an Annual Quote

Biolog Awarded Patent for Phenotype Microarray Technology

NEW YORK, March 2 (GenomeWeb News) - Biolog yesterday said that it has received a new patent for its Phenotype Microarray technology - the 21st patent for the company's cellular assay technology platform.

The patent, number US 6,686,173, entitled, "Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device," protects a method for comparing the phenotypes of two or more microorganisms within a microwell device.

The patent covers the phenotypic analysis of eukaryotic as well as prokaryotic cells. The company said that its Phenotype Microarray technology has already been applied to a number of bacteria and fungi, including Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus spp., Bacillus spp., Saccharomyces cerevisiae, Candida albicans, and Aspergillus spp.

In June, Biolog received an SBIR grant from the National Cancer Institute to extend the platform to human and mouse cell lines.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.